Every record from Janoshik · page 40
The single largest contributor to the index and the de facto reference against which the other five labs are calibrated here. Measured offset against the reference laboratory is 0.000 pp. Full laboratory profile →
| Report | Compound | Supplier | Lot | Quarter | Purity % | Water % | Recovery % | Provenance | Flags | Result |
|---|---|---|---|---|---|---|---|---|---|---|
| AX-2025-019114 | BPC-157 | JEEP | JEEP-2507-V4206 | 2025-Q3 | 99.35 | 5.23 | 107.1 | Supplier-supplied | 2 | MARGINAL |
| AX-2025-020127 | Retatrutide | GGPeps | GGPE-2508-E8992 | 2025-Q3 | 98.25 | 2.78 | 102.7 | Supplier-supplied | 1 | MARGINAL |
| AX-2025-019140 | PEG-MGF | TFC | TFC-2507-M4201 | 2025-Q3 | 98.01 | 3.80 | 92.6 | Supplier-supplied | 2 | MARGINAL |
| AX-2025-019012 | MOTS-c | JEEP | JEEP-2507-W2442 | 2025-Q3 | 99.61 | 4.94 | — | Supplier-supplied | 1 | MARGINAL |
| AX-2025-018724 | MK-677 (Ibutamoren mesylate) | QSC | QSC-2507-F6894 | 2025-Q3 | 99.50 | 4.47 | 101.9 | Supplier-supplied | 1 | FAIL |
| AX-2025-021260 | Pemvidutide | BCH | BCH-2506-G6608 | 2025-Q3 | 98.37 | 5.48 | 93.0 | Supplier-supplied | 3 | MARGINAL |
| AX-2025-020569 | Vilon | SSA | SSA-2508-B6325 | 2025-Q3 | 99.74 | 5.87 | 97.7 | Supplier-supplied | 0 | FAIL |
| AX-2025-020285 | 5-Amino-1MQ | MKM | MKM-2503-H2930 | 2025-Q3 | 98.88 | 5.06 | 91.9 | Laboratory-retained | 1 | FAIL |
| AX-2025-019987 | Semaglutide | ERP | ERP-2508-S6110 | 2025-Q3 | 98.69 | 2.54 | — | Laboratory-retained | 0 | PASS |
| AX-2025-019311 | MOTS-c | TFC | TFC-2503-C7376 | 2025-Q3 | 99.14 | 4.74 | 94.0 | Supplier-supplied | 1 | MARGINAL |
| AX-2025-020771 | Semaglutide | SGN | SGN-2502-F9601 | 2025-Q3 | 99.46 | 5.10 | 90.9 | Supplier-supplied | 0 | PASS |
| AX-2025-020286 | 5-Amino-1MQ | MKM | MKM-2503-H2930 | 2025-Q3 | 99.93 | 5.09 | — | Supplier-supplied | 1 | FAIL |
| AX-2025-020120 | Retatrutide | GGPeps | GGPE-2508-E8992 | 2025-Q3 | 98.03 | 2.54 | 105.5 | Supplier-supplied | 1 | MARGINAL |
| AX-2025-019236 | NAD+ | TFC | TFC-2505-C6056 | 2025-Q3 | 99.71 | 12.01 | 96.8 | Supplier-supplied | 1 | FAIL |
| AX-2025-021311 | GHRP-2 | BCH | BCH-2506-L7534 | 2025-Q3 | 97.91 | 7.98 | 90.8 | Laboratory-retained | 2 | FAIL |
| AX-2025-020827 | GHRP-6 | SGN | SGN-2504-X1136 | 2025-Q3 | 98.62 | 3.52 | 106.7 | Supplier-supplied | 1 | FAIL |
| AX-2025-020733 | Tirzepatide | SGN | SGN-2506-J8941 | 2025-Q3 | 96.51 | 2.52 | — | Supplier-supplied | 3 | FAIL |
| AX-2025-020517 | GHK-Cu | KP | KP-2502-C5740 | 2025-Q3 | 98.46 | 4.22 | 105.0 | Supplier-supplied | 0 | PASS |
| AX-2025-020495 | CJC-1295 with DAC | KP | KP-2506-L5639 | 2025-Q3 | 99.80 | 5.00 | — | Supplier-supplied | 0 | PASS |
| AX-2025-020361 | Liraglutide | MKM | MKM-2508-P3929 | 2025-Q3 | 98.55 | 6.99 | 103.4 | Supplier-supplied | 1 | MARGINAL |
| AX-2025-020110 | Tirzepatide | GGPeps | GGPE-2502-J8885 | 2025-Q3 | 98.19 | 5.79 | 93.6 | Supplier-supplied | 2 | MARGINAL |
| AX-2025-020111 | Tirzepatide | GGPeps | GGPE-2502-J8885 | 2025-Q3 | 98.29 | 5.48 | 106.3 | Supplier-supplied | 2 | MARGINAL |
| AX-2025-018686 | Dihexa | QYB | QYB-2503-Y6694 | 2025-Q3 | 99.93 | 7.89 | 105.8 | Supplier-supplied | 0 | PASS |
| AX-2025-020122 | Retatrutide | GGPeps | GGPE-2508-E8992 | 2025-Q3 | 97.62 | 2.84 | 103.9 | Supplier-supplied | 1 | MARGINAL |
| AX-2025-020034 | Retatrutide | ERP | ERP-2506-C7220 | 2025-Q3 | 98.26 | 5.59 | 100.9 | Supplier-supplied | 3 | MARGINAL |
| AX-2025-019690 | BPC-157 | HJ | HJ-2503-M3088 | 2025-Q3 | 99.93 | 5.22 | 97.1 | Supplier-supplied | 0 | PASS |
| AX-2025-019200 | TB-500 | TFC | TFC-2503-R5803 | 2025-Q3 | 98.54 | 3.55 | — | Buyer-sourced | 1 | MARGINAL |
| AX-2025-018865 | Desmopressin | QSC | QSC-2505-N8999 | 2025-Q3 | 99.48 | 4.06 | 100.2 | Supplier-supplied | 0 | PASS |
| AX-2025-021298 | AOD-9604 | BCH | BCH-2504-B8049 | 2025-Q3 | 98.75 | 2.71 | 97.3 | Supplier-supplied | 0 | PASS |
| AX-2025-021248 | L-Glutathione (reduced) | BCH | BCH-2508-X6429 | 2025-Q3 | 97.48 | 6.36 | — | Supplier-supplied | 0 | FAIL |
| AX-2025-020795 | PT-141 (Bremelanotide) | SGN | SGN-2505-A9617 | 2025-Q3 | 98.07 | 3.82 | 93.4 | Laboratory-retained | 1 | FAIL |
| AX-2025-020260 | CJC-1295 (no DAC) | MKM | MKM-2504-K2481 | 2025-Q3 | 97.93 | 4.70 | 97.3 | Supplier-supplied | 1 | FAIL |
| AX-2025-019195 | IGF-1 LR3 | TFC | TFC-2508-H6012 | 2025-Q3 | 97.75 | 5.55 | — | Supplier-supplied | 0 | PASS |
| AX-2025-018611 | Pemvidutide | QYB | QYB-2502-V5083 | 2025-Q3 | 99.29 | 3.73 | 94.5 | Supplier-supplied | 3 | MARGINAL |
| AX-2025-021296 | AOD-9604 | BCH | BCH-2504-B8049 | 2025-Q3 | 98.96 | 2.53 | 97.1 | Supplier-supplied | 0 | PASS |
| AX-2025-020900 | Semaglutide | CPC | CPC-2504-G2724 | 2025-Q3 | 98.54 | 5.04 | 104.8 | Supplier-supplied | 2 | MARGINAL |
| AX-2025-020794 | PT-141 (Bremelanotide) | SGN | SGN-2505-A9617 | 2025-Q3 | 98.35 | 3.82 | 97.3 | Supplier-supplied | 1 | FAIL |
| AX-2025-019201 | TB-500 | TFC | TFC-2503-R5803 | 2025-Q3 | 98.86 | 3.37 | 92.9 | Supplier-supplied | 1 | MARGINAL |
| AX-2025-020962 | CJC-1295 (no DAC) | CPC | CPC-2503-R2710 | 2025-Q3 | 97.19 | 6.30 | 103.9 | Supplier-supplied | 1 | FAIL |
| AX-2025-020744 | Sermorelin | SGN | SGN-2502-Y8932 | 2025-Q3 | 98.75 | 4.81 | — | Supplier-supplied | 0 | PASS |